
Article 1 
The measures of the Portuguese authority Infarmed taken by letter of 29 July 2005 (DGREE/VPS/086/05 — Case No 9.5.1 — 329/2005) against the marketing of the in-vitro diagnostic medical device ‘HIV 1 & 2 Ab’ manufactured by the Italian company Medical Biological Service SRL are justified.
Article 2 
This Decision is addressed to the Portuguese Republic.
Done at Brussels, 2 December 2008.
For the Commission
Günter VERHEUGEN
Vice-President